Clinical study of shengmai injection on the regulation of TNF-αand IL-8 during cardiopulmonary resuscitation
- VernacularTitle:生脉注射液对心肺复苏中肿瘤坏死因子-α、白细胞介素-8调控的临床研究
- Author:
Mengqiu YI
;
Xiaoli SUN
;
Xuebing ZHENG
- Publication Type:Journal Article
- Keywords:
Cardiopulmonary resuscitation;
Shengmai injection;
Systemic inflammatory response syndrome;
TNF-α;
IL-8
- From:
Clinical Medicine of China
2008;24(5):429-431
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the mechanism of shengmai injection on relieving ischemia reperfusion injury and antagonizing systemic inflammatory response syndrome by regulating cytokines when it was applied at the early stage of cardiopulmonary resuscitation(CPR).Methods 40 cases suffering from cardiac arrest and had their heart beat recovered through CPR for more than 24 hours were randomly divided into SMI group and control group(20 cases for each).The patients in the two groups were treated with common therapeutics based on the CPR,but the patients in SMI group were intravenously dropped with SMI in the early period of PLS phase,then the changes of serum concentration of TNF-α and IL-81h,2h,6h,12h and24h after CPR in the two groups was compared.Results The concentrations of serum TNF-α and IL-8 stepped up gradually after resuscitation and the levels of TNF-αand IL-8 in SMI group were lower than that of the control group at 1h,2h,6h,12h and 24h after resuscitation(P＜0.05).Conclusion SMI functions to relieve ischemia reperfusion injury by regulating cytokines and antagonizing systemic inflammatory response syndrome.
